Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials

Clinical outcomes of baricitinib in patients with systemic lupus erythematosus: Pooled analysis of SLE-BRAVE-I and SLE-BRAVE-II trials

Saved in:

Bibliographic Details
Main Authors:	Juntao Yin, Yantao Hou, Chaoyang Wang, Changjiang Qin
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12043178/?tool=EBI
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

To Be Brave
by: Sam Sinclair
Published: (2025-07-01)

Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE)
by: Shunichi Shiozawa
Published: (2025-07-01)

Brave the Storm
by: Jacqueline Murray Loring
Published: (2020-06-01)

The Free and the Brave : the story of the American people /
by: Graff, Henry F.
Published: (1980)

Performance of the proposed ACR–EULAR classification criteria for systemic lupus erythematosus (SLE) in a cohort of patients with SLE with neuropsychiatric symptoms
by: Tom W J Huizinga, et al.
Published: (2019-06-01)

Clinical features of patients with systemic lupus erythematosus (SLE) attending the SLE outpatient clinic at Universitas Hospital in Bloemfontein, South Africa
by: Robyn Carey, et al.
Published: (2008-02-01)

Understanding the impact of delayed diagnosis and misdiagnosis of systemic lupus erythematosus (SLE)
by: Jordan L. Mitchell
Published: (2024-11-01)

Braving the street. The anthropology of homelessness
by: Santiago Bachiller
Published: (2024-06-01)

AN ANALYSIS OF DEIXIS ON THE CHARACTERS IN BRAVE MOVIE
by: Yasinta Trililis Anjelina Maduwu, et al.
Published: (2024-09-01)

Anti-ribosomal-P protein antibodies and systemic lupus erythematosus (SLE): in a cross-sectional study of Danish adult patients with SLE, no significant association is found between anti-ribosomal-P and neuropsychiatric SLE
by: Anne Voss, et al.
Published: (2025-08-01)

Systemic Lupus Erythematosus (SLE): A review on the prevalence, clinical manifestation, and disease assessment
by: Malarvili Selvaraja, et al.
Published: (2020-09-01)

Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
by: Abraham Zlotogorski, et al.
Published: (2024-12-01)

Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain
by: Alina Boteanu, et al.
Published: (2025-05-01)

Clinical correlations of serum anti-dsDNA immunoglobulin subfamilies in patients with systemic lupus erythematosus (SLE)
by: Jing Jing Wang, et al.
Published: (2025-12-01)

Differences in gestational age at preterm birth can predict future cardiovascular events in systemic lupus erythematosus (SLE)
by: May Ching Soh, et al.
Published: (2025-06-01)

Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort.
by: Syahrul Sazliyana Shaharir, et al.
Published: (2021-01-01)

‘Brave Ephemeral World’. Reflections on Non-Linearity in Screen Arts
by: Maloletkin Maksim F.
Published: (2025-06-01)

The “Brave New World” of biosimilars: Look before you leap!
by: Lathika Vasu Kamaladevi
Published: (2024-12-01)

A Brave New World? Pronatalism and the Future of Reproductive Technologies
by: Yong Lee Ji
Published: (2024-12-01)

A Brave New World: AI as a Nascent Regime?
by: Jasmin Cowin, et al.
Published: (2023-08-01)

30 years on: A brave new world or an unfolding disaster?
by: Stuart Turner
Published: (2022-06-01)

Fungal microbiome in gut of systemic lupus erythematosus (SLE)-prone mice (pristane and FCGRIIb deficiency), a possible impact of fungi in lupus.
by: Thanya Cheibchalard, et al.
Published: (2024-01-01)

Cutaneous vasculitis in SLE
by: Romy Kallas
Published: (2020-10-01)

SLE: reconciling heterogeneity
by: Peter Izmirly, et al.
Published: (2019-12-01)

Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen
by: Michael H. Lee, et al.
Published: (2018-01-01)

Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)
by: Chiara Tani, et al.
Published: (2024-07-01)

City of brave demons: The formation of an urban identity civil code of Ekaterinburg
by: Alina O. Barsukova, et al.
Published: (2024-03-01)

A judge must not be influenced by fear. Must a judge be brave?
by: Martin Sunnqvist
Published: (2025-04-01)

Cell-bound complement activation products associate with lupus severity in SLE
by: Richard A Furie, et al.
Published: (2020-10-01)

Chinese SLE Treatment and Research Group Registry: III. Association of Autoantibodies with Clinical Manifestations in Chinese Patients with Systemic Lupus Erythematosus
by: Jing Li, et al.
Published: (2014-01-01)

Braving the SARS-CoV-2 pandemic – Quandary of health-care workers
by: Arjun Gurmeet Singh, et al.
Published: (2020-01-01)

The Classroom as a “Brave Space” in Jacqueline Woodson’s <i>Harbor Me</i>
by: Wendy Rountree
Published: (2025-04-01)

Georges Marbeck, Un crime de braves gens. Hautefaye – Périgord 1870
by: Eric Wenzel
Published: (2013-03-01)

WCN24-757 NEUROPSYCHIATRIC SLE (NPSLE) IN CHILDREN AND ADOLESCENTS WITH LUPUS NEPHRITIS
by: Eugene Yu Hin Chan, et al.
Published: (2024-04-01)

Glucocorticoid tapering early in the course of juvenile SLE: association with lupus low disease activity state and outcomes
by: Seza Ozen, et al.
Published: (2025-05-01)

Dysregulation of T Follicular Helper and Regulatory Cells in <i>IRF5</i>-SLE Homozygous Risk Carriers and Systemic Lupus Erythematosus Patients
by: Bharati Matta, et al.
Published: (2025-03-01)

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
by: Maria Juarez, et al.
Published: (2025-05-01)

A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap.
by: Paula S Ramos, et al.
Published: (2011-12-01)

The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS
by: Mandy Ming Yan Wong, et al.
Published: (2025-06-01)

Systemic lupus erythematosus related thrombotic microangiopathy: A retrospective study based on Chinese SLE Treatment and Research Group (CSTAR) registry
by: Yupei Zhang, et al.
Published: (2025-03-01)